Expanding access to epilepsy care in western Kenya (BEACON)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

BEACON is a cluster-randomized trial comparing task-sharing supported by an epilepsy medical records system (EMRS) and patient-tracking to usual care across clinics in western Kenya. Clusters of clinics will implement the BEACON intervention, where non-specialist health workers use the EMRS to manage follow-up, medication adherence, and referrals. Outcomes include treatment adherence, retention in care, seizure severity, perceived stigma, and quality of life, with data collected at baseline, 6, 12, and potentially 18 months. The study also includes a cost-effectiveness analysis and efforts to build local clinical and research capacity for epilepsy care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals ≥12 years
* Residents of Busia or Trans Nzoia County
* Diagnosed with possible epilepsy through initial screening and confirmed diagnosis by an epilepsy-trained professional with the BEACON project or physician
* Have a diagnosis of epilepsy but are not adherent to antiseizure medication treatment.

Exclusion Criteria:

* Individuals receiving care from a neurosurgeon or neurologist for a serious brain disorder
* Unable or unwilling to provide voluntary informed consent or assent (12-18 years)

Where it's running

• Moi University
  Eldoret, Kenya Recruiting

Study contacts

• Principal investigator: Jane von Gaudecker, PhD — Indiana University
• Study coordinator: Jane von Gaudecker, PhD
• Email: jvongaud@iu.edu
• Phone: 317-278-2758

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• RAP-219 long-acting injectable safety and PK study in healthy adults

  This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.

  Recruiting Phase 1 Rapport Therapeutics Inc. · Adelaide · NCT07923097

• Why People with Epilepsy Get More Infections

  This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.

  Recruiting University of Aberdeen · Aberdeen · NCT07903168

• Long-Term Epilepsy Outcomes in Children After Perinatal Stroke

  This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07898397

• Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy

  This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens, Picardie · NCT07888543

• One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions

  A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07883720

• Advanced 7T fMRI for brain function in epilepsy and brain injuries

  This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.

  Recruiting Imago 7 Fondazione di Ricerca onlus · Pisa, Italy · NCT07865546

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.